Delta-9-tetrahydrocannabinol-induced catalepsy in mice is enhanced by pretreatment with flurazepam or chlordiazepoxide

R. Pertwee,S. Greentree

DOI: https://doi.org/10.1016/0028-3908(88)90130-X

IF: 5.273

1988-05-01

Neuropharmacology

Abstract:

What problem does this paper attempt to address?

Seroprevalence and risk factors for rubella infection in pregnant women attending a tertiary hospital in Kano-Nigeria

Safiya Usman Zahradeen,Ibrahim Danladi Muhammad,Natalia Adamou,Ayyuba Rabiu,Mustapha Ahmed Yusuf,Samaila Adavuruku Danjuma Shuaibu,Garba Ibrahim

DOI: https://doi.org/10.11604/pamj.2023.46.97.39433

2023-12-04

Abstract:Introduction: rubella is a leading cause of vaccine preventable birth defects especially in developing countries. Acquisition of infection with the rubella virus in early pregnancy exposes the fetus to a very high chance of developing congenital rubella syndrome. The neonate is born with multiple abnormalities with the triad of congenital cataract, deafness and cardiovascular abnormalities like ventricular septal defect or patent ductus arteriosus. Limited data exist on the seroprevalence of rubella antibodies in pregnant women in Nigeria. The aim of this study was to determine the seroprevalence of rubella antibodies in pregnant women attending antenatal clinic in Aminu Kano Teaching Hospital, Kano State. Methods: the study was a cross-sectional study involving one hundred and sixty-three pregnant women attending antenatal clinic of Aminu Kano Teaching Hospital in Kano, Nigeria. Interviewer administered questionnaire was used to collect sociodemographic data and risk factors. Blood samples were taken from consenting pregnant women during antenatal care and samples were subjected to antibody testing (IgG and IgM). Descriptive analysis was done for sociodemographic data and seroprevalence of rubella. Chi-square tests were used to determine associations. Results: one hundred and sixty-three pregnant women were recruited for the study. The participants´ age ranged from 18 to 41 years with mean age of 27.60±5.7 years. The overall rubella seroprevalence was found to be 68.7%. The seroprevalence of specific anti-Rubella virus IgM and IgG was found to be 58.4% and 37.3% respectively while prevalence of having both anti-Rubella virus IgG and IgM in the women was found to be 26.4%. Non-formal education and immunodeficiency was found to be associated with rubella infection (P-value of 0.018 and 0.001 respectively). Conclusion: the study found a high prevalence of anti-Rubella virus immunoglobulins in asymptomatic pregnant women attending antenatal care in our facility with immunodeficiency and non-formal education found to be significant risk factors.
The impact of sub-national heterogeneities in demography and epidemiology on the introduction of rubella vaccination programs in Nigeria

Taishi Nakase,Tenley Brownwright,Oyeladun Okunromade,Abiodun Egwuenu,Oladipo Ogunbode,Bola Lawal,Kayode Akanbi,Gavin Grant,Orji O. Bassey,Melissa M. Coughlin,Bettina Bankamp,Ifedayo Adetifa,Jessica Metcalf,Matthew Ferrari

DOI: https://doi.org/10.1101/2024.02.18.24302994

2024-02-20

Abstract:Rubella infection during pregnancy can result in miscarriage or infants with a constellation of birth defects known as congenital rubella syndrome (CRS). When coverage is inadequate, rubella vaccination can increase CRS cases by increasing the average age of infection. Thus, the World Health Organisation recommends that countries introducing rubella vaccine be able to vaccinate at least 80% of each birth cohort. Previous studies have focused on national-level analyses and have overlooked sub-national variation in introduction risk. We characterised the sub-national heterogeneity in rubella transmission within Nigeria and modelled local rubella vaccine introduction under different scenarios to refine the set of conditions and strategies required for safe rubella vaccine use. Across Nigeria, the basic reproduction number ranged from 2.6 to 6.2. Consequently, the conditions for safe vaccination varied across states with low-risk areas requiring coverage levels well below 80%. In high-risk settings, inadequate routine coverage needed to be supplemented by campaigns that allowed for gradual improvements in vaccination coverage over time. Understanding local heterogeneities in both short-term and long-term epidemic dynamics can permit earlier nationwide introduction of rubella vaccination and identify sub-national areas suitable for program monitoring, program improvement and campaign support.

Infectious Diseases (except HIV/AIDS)
Rubella immunity among pregnant women and the burden of congenital rubella syndrome (CRS) in India, 2022

Devika Shanmugasundaram,Rajlakshmi Viswanathan,Amy K Winter,Anjoo Agarwal,Bidisha Roychowdhury,Divya Muliyil,G R V Prasad,K Pushpalatha,Mamatha Gowda,Pradibha Singh,J Priyasree,Rajeswari Bonu,Sangam Jha,Saubhagya Kumar Jena,Shuchi Jain,Vanita Suri,Vidyavathi Hebbale,Amita Jain,Asha Mary Abraham,Baijayantimala Mishra,Binod Kumar Pati,Debasis Biswas,Deepashri Pratkeye,M Ashok,Mini P Singh,Rahul Dhodapkar,Raja Ray,Ravishekhar Gadepalli,R K Ratho,Sudha Rani,Suruchi Shukla,Syed Ali A,Vijay Lakshmi Nag,R Sabarinathan,V Saravana Kumar,Padma Priya R,Bhagirathi Dwibedi,Gajanan Sapkal,Himabindu Singh,Kuldeep Singh,Lokesh Tiwari,Manish Jain,Nivedita Mondal,Priya Sreenivasan,S Mahantesh,Sanjay Verma,Shally Awasthi,Shikha Malik,Sridhar Santhanam,Supratim Datta,Amber Kumar,Bhabesh Kant Chowdhary,Daisy Khera,Mahendra Jain,Praveen Kumar,Sananda Pati,Shalini Tripathi,Manoj Murhekar

DOI: https://doi.org/10.1016/j.vaccine.2024.06.044

IF: 4.169

2024-10-24

Vaccine

Abstract:Background: India aims to eliminate rubella and congenital rubella syndrome (CRS) by 2023. We conducted serosurveys among pregnant women to monitor the trend of rubella immunity and estimate the CRS burden in India following a nationwide measles and rubella vaccination campaign. Methods: We surveyed pregnant women at 13 sentinel sites across India from Aug to Oct 2022 to estimate seroprevalence of rubella IgG antibodies. Using age-specific seroprevalence data from serosurveys conducted during 2017/2019 (prior to and during the vaccination campaign) and 2022 surveys (after the vaccination campaign), we developed force of infection (FOI) models and estimated incidence and burden of CRS. Results: In 2022, rubella seroprevalence was 85.2% (95% CI: 84.0, 86.2). Among 10 sites which participated in both rounds of serosurveys, the seroprevalence was not different between the two periods (pooled prevalence during 2017/2019: 83.5%, 95% CI: 82.1, 84.8; prevalence during 2022: 85.1%, 95% CI: 83.8, 86.3). The estimated annual incidence of CRS during 2017/2019 in India was 218.3 (95% CI: 209.7, 226.5) per 100, 000 livebirths, resulting in 47,120 (95% CI: 45,260, 48,875) cases of CRS every year. After measles-rubella (MR) vaccination campaign, the estimated incidence of CRS declined to 5.3 (95% CI: 0, 21.2) per 100,000 livebirths, resulting in 1141 (95% CI: 0, 4,569) cases of CRS during the post MR-vaccination campaign period. Conclusion: The incidence of CRS in India has substantially decreased following the nationwide MR vaccination campaign. About 15% of women in childbearing age in India lack immunity to rubella and hence susceptible to rubella infection. Since there are no routine rubella vaccination opportunities for this age group under the national immunization program, it is imperative to maintain high rates of rubella vaccination among children to prevent rubella virus exposure among women of childbearing age susceptible for rubella.
Rubella epidemiology in Lesotho after vaccine introduction: a five-year review, 2018-2022

Thabelo Makhupane,Dsk Habedi

DOI: https://doi.org/10.1186/s12889-024-20081-z

IF: 4.5

2024-10-18

BMC Public Health

Abstract:Background: The rubella virus is a major contributor to birth defects globally and is preventable by vaccination. In 2020, the world was supposed to be free of both rubella and Congenital Rubella Syndrome (CRS) however this goal has yet to be realized with only 93 out of 194 WHO member states confirmed rubella-free in 2020. Methods: A retrospective measles and rubella case-based surveillance data record review was conducted from 2018 to 2022 to document rubella epidemiology after the introduction of rubella vaccination in Lesotho and progress toward elimination. All samples submitted for surveillance purposes and tested for rubella were considered but only filtered according to inclusion and exclusion criteria. Descriptive statistics were used to analyse the data. Results: Of the 1041 samples that were tested for rubella between 2018 and 2022, 10 (1%) were confirmed measles positive and were excluded from further analysis. The median age of the respondents was 6.0 (IQR 4.0-8.0.) years. About 643 (62.4%) of respondents were in the age category of 5 - <13 years. Rubella prevalence was 1% (95% CI; 0.5 -1.8%). The non-measles, non-rubella rash illness rate of 2 per 100 000 population was obtained at the national level each year of the study period but by only 2 of the country's 10 districts in 2021. Conclusions: The study showed low rubella prevalence. Rubella infection was predominant in those aged 5 - < 13 years. Failure to meet surveillance targets at certain time points during the study period may have led to an underestimation of rubella cases. There is a need to improve the quality of measles and rubella surveillance in Lesotho. Supplementary immunization activities would also be useful in closing immunity gaps, limiting outbreaks, and advancing rubella and CRS elimination in Lesotho.
Medical x-ray exposure of the human embryo and fetus.

I. Syed,E. Samols

DOI: https://doi.org/10.1097/00004032-198201000-00006

Health Physics

Abstract:In a period of 2 yr. 6 pregnant women who were not aware that they were pregnant at the time of radiological examination of their abdomen and pelvis, wanted to know the radiation dose received by their embryo or fetus. Radiation dose estimate to the embryo or fetus was made by performing dosimetry with a phantom and the equipment utilized for the actual procedure. The dose to the embryo or fetus varied between less than 50 mrads and 3.52 rads when fluoroscopy was also performed. As the radioimmunoassay test now enables immediate, (same day) detection of pregnancy after day 21 of the menstrual cycle, it is reasonable to recommend that (1) the test be performed in all patients whose pregnancy status is uncertain and (2) that a positive result will ensure minimization of any necessary diagnostic radiation dose. The risk to the embryo or fetus is discussed.
Sociodemographic and Economic Characteristics of Susceptibility to Rubella among Women Preparing for Pregnancy in Rural China

Fangchao Liu,Shikun Zhang,Jue Liu,Qiaomei Wang,Haiping Shen,Yiping Zhang,Min Liu

DOI: https://doi.org/10.1016/j.ijid.2017.07.013

IF: 12.073

2017-01-01

International Journal of Infectious Diseases

Abstract:Objectives: Infection with rubella virus during pregnancy can result in congenital defects and adverse pregnancy outcomes. The risk of rubella infection is greatly determined by the level of rubella antibodies in the serum. A survey of rubella antibody seronegativity rates was conducted in 780 000 women in rural China who were planning a pregnancy, in order to evaluate the herd susceptibility in different age groups and by high, middle, and low GDP per capita regions.Methods: In order to evaluate the herd susceptibility to rubella, a nationwide population-based study of rural Chinese women who were planning to have a baby and who were aged 21-49 years was instigated. As apart of the National Free Pre-conception Health Examination Project covering 29 provinces in 2012, a physical check-up program was provided to women who planned to become pregnant within the next 6 months. All medical data were from serological samples tested by ELISA, and the participants' immunity status was categorized based on levels of rubella antibodies. Economic data were also collected to explore the association between herd susceptibility and socioeconomic characteristics in the women of childbearing age.Results: A total 264 306 of 782 293 recruited women preparing for pregnancy tested susceptible to rubella (33.79%). The seronegativity rate in women with a history of vaccination was significantly lower than that in women who had not received the vaccination or did not know their vaccination history(23.76%, 33.70%, and 35.68%, respectively). The seronegativity rates were 26.89% , 37.86%, and32.61% in high, middle, and low GDP per capita areas, respectively. After stratified analysis and adjusting for other factors by multiple logistic regression, the lower seronegativity rates in women in high GDP per capita regions compared to women in middle and low GDP per capita regions remained in the different age groups and subgroups of immunization history.Conclusions: There is a clear difference in rubella-specific susceptibility among rural women preparing for pregnancy of different sociodemographic and economic backgrounds. The number of rubella-susceptible rural women preparing for pregnancy, especially in relatively low GDP per capita regions in China, was high. Offering rubella vaccination to women who are rubella-susceptible and who plan to become pregnant should become one of the priorities in the field of public health work in China. (C) 2017 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
Rubella antibody levels in the healthy Chinese population: a meta-analysis

Yaning Zhuo,Zhaojun Lu,Xuechao Zhang,Xiaoping Zhang,Yingying Yang,Jiayin Han,Jian Du,Yuyang Xu

DOI: https://doi.org/10.3389/fimmu.2024.1472189

IF: 7.3

2024-11-13

Frontiers in Immunology

Abstract:Objectives: To gain a comprehensive understanding of rubella seroprevalence in the healthy population in China and to offer data-driven support for the goal of rubella elimination. Methods: CNKI, Wanfang database, VIP database, CBM, PubMed, web of Science, and Embase databases were searched to collect studies reporting the positive rate of rubella antibody among the Chinese healthy populations between 2001 and 2022. We conducted a meta-analysis using R language, and data were combined using random effects model. Results: A total of 97 studies were included, encompassing a sample size of 103,018. Meta-analysis showed that the overall prevalence of rubella antibody positivity in the Chinese healthy population was 77.29% (95% CI: 75.26-79.33). The prevalence of rubella antibody varied significantly based on age and vaccination status. Among the age groups studied, the <1-year-old group exhibited the lowest positivity rate for rubella antibody at 47.87% (95% CI: 41.53-54.21),while the ≥50 years old group showed the highest positivity rate at 85.43% (95% CI: 81.01-89.85); individuals with a history of vaccination demonstrated a higher antibody positivity rate compared to those without vaccination history. Conclusions: The prevalence of rubella antibody in healthy Chinese population is relatively low. In order to establish a solid immunity threshold levels, it requires conducting timely immunization programs on key groups such as middle school students and the women of childbearing age on the basis of ensuring a high level of rubella-containing-vaccines (RCV) coverage, so as to achieve the goal of eliminating rubella. Systematic review registration: https://www.crd.york.ac.uk/PROSPERO/, identifier CRD42024607949.

immunology
Symbol Spaced Adaptive MIMO Equalization for Ultrahigh Bit Rate Metro Coherent Optical Links

A. Gorshtein,D. Sadot

DOI: https://doi.org/10.1109/LPT.2013.2238919

IF: 2.6

2013-03-01

IEEE Photonics Technology Letters

Abstract:A novel approach to symbol spaced adaptive multiple-input-multiple-output (MIMO) equalization is proposed. Different functionalities are defined for static versus adaptive equalizers, to minimize noise enhancement. Static equalizers are used for anti-aliasing filtering and bulk CD compensation, and a newly proposed modified-LMS-based adaptive MIMO equalizer is used to compensate for fiber random impairments such as residual CD and PMD. In addition, the proposed technique enables the use of low-cost reduced bandwidth components in both transmit and receive sides, and supports aggressive in-line optical filtering in the existing WDM network. Moreover, the proposed technique perfectly suits coherent metro applications, allowing significant power savings in application specific integrated circuit implementation.
Do adolescents need a rubella vaccination campaign? Rubella serosurvey among healthy children in Hangzhou, China

Xiaozhen Wang,Yuyang Xu,Xuechao Zhang,Xiaoping Zhang,Jian Du,Xinren Che,Wenwen Gu,Jun Wang,Wei Jiang,Yan Liu

DOI: https://doi.org/10.1080/21645515.2023.2254536

Abstract:The aim of this study was to evaluate the seroprevalence of rubella antibodies and factors associated with antibody seropositivity after vaccination among healthy children aged 14 and below. A multi-stage stratified random sampling method was employed to recruit participants for the rubella serological test. An enzyme-linked immunosorbent assay method was used to detect human IgG antibodies with avidity for rubella virus in the sera of participants. Univariate and multivariate analyses were used to analyze associations between variables. A total of 778 subjects were included in the subsequent analysis. The overall positive rate of rubella antibody was 83.0% (95%CI: 80.2-85.5%), and the overall geometric mean concentration (GMC) was 58.05 IU/ml. In multivariate analysis, gender, residence, birth year group, and time since the last rubella-containing vaccines (RCV) vaccination were significantly associated with the seroprevalence of rubella antibodies. Our study showed a decreasing trend in rubella antibody positivity and GMC in the population aged five to 14 years. Therefore, we recommend a catch-up dose of RCV for adolescents and young people aged over 14 years not yet vaccinated.
Congenital rubella syndrome, a case series

Olanrewaju Medu,Priyanka Mahajan,Maurice Hennink,Laurel Stang,Maureen Anderson,Ben Tan,Abimbola Oyenubi,Mireille Plamondon,Marina I Salvadori,Kristyn Franklin,Courtney Primeau,Joanne Hiebert,Jessica Minion,Tania Diener

DOI: https://doi.org/10.14745/ccdr.v50i78a05

2024-07-24

Abstract:Rubella, or German measles, is a vaccine-preventable disease. Rubella infection is usually mild; however, infection in pregnancy is associated with severe outcomes for the baby, including pregnancy loss or a combination of developmental defects called congenital rubella syndrome. Within the last ten-year period, two cases of congenital rubella syndrome in Saskatchewan were reported to the provincial ministry and the Public Health Agency of Canada of the newborns of mothers who had recently arrived from Sub-Saharan Africa. Both infants had multiple health complications at birth consistent with congenital rubella and tested positive for the rubella virus. The article discusses the challenges encountered by the healthcare system in diagnosing, investigating, monitoring and managing cases of congenital rubella syndrome to prevent further sporadic transmission. The article emphasizes the need to provide additional support for cases and their households, especially new Canadians with less support to comply with public health advice and the importance of routine immunization to eliminate rubella globally.
Vulnerability Analysis of Web-based Applications

M. Cova,Viktoria Felmetsger,Giovanni Vigna

DOI: https://doi.org/10.1007/978-3-540-72912-9_13

Abstract:
[100 years of child psychology research].

H. Hetzer

1983-02-17

Abstract:
Rubella Immunity in Women of Childbearing Age, Eight Years After the Immunization Program in Iran

Rahim Barari Sawadkohi,Amin Zarghami,Fatemeh Izadpana,Mohammad Pournasrollah

DOI: https://doi.org/10.5812/ircmj.10431

2014-07-05

Iranian Red Crescent Medical Journal

Abstract:BACKGROUND: Rubella is a viral disease with a worldwide distribution. Mass vaccination campaigns have increased the vaccine coverage in the world with substantial impact on reduction of rubella infections. In Iran, the national measles-rubella campaign, targeting individuals 5-25 years old, was initiated in 2003 and mass childhood vaccination against measles, rubella and mumps has continued ever since.OBJECTIVES: The aim of this study was to evaluate the efficacy of routine vaccination on rubella immunity among women of childbearing age in Babol, north of Iran.PATIENTS AND METHODS: This cross-sectional study was conducted on 812 women of childbearing age living in Babol, north of Iran, in 2011. Twelve samples were excluded from the study because of inadequate sera amounts. Serum samples were examined for presence of rubella-specific IgG antibodies by means of quantitative ELISA.RESULTS: From a total of 800 samples in this study, rubella IgG seropositivity was seen in 786 (98.3% [95% CI = %97.5-%99.1]) cases. The maximum IgG seropositivity (99.2%) was seen in the age group of 21-25 years old and the lowest immunity (87.7%) was in the group of above 30 years old.CONCLUSIONS: Our data indicated that the rate of seropositivity to rubella virus in our population was high, suggesting that vaccination has been successful in Babol, reducing the likelihood of congenital rubella infection.

medicine, general & internal
A Serological Survey of Measles and Rubella Antibodies among Different Age Groups in Eastern China

Rui Yan,Hanqing He,Xuan Deng,Yang Zhou,Xuewen Tang,Yao Zhu,Hui Liang,Yaping Chen,Mengya Yang,Yuxia Du,Can Chen,Jiaxin Chen,Shigui Yang,RIDPHE Group

DOI: https://doi.org/10.3390/vaccines12080842

2024-07-26

Vaccines

Abstract:Background: Measles and rubella are vaccine-preventable diseases targeted for elimination in most World Health Organization regions, and China is considered to have momentum towards measles elimination. Therefore, this study aimed to assess the population immunity levels against measles and rubella in Zhejiang Province in China in order to provide valuable insights for informing future public health measures and contributing to the ongoing global campaign against these diseases. Materials and methods: A cross-sectional serological survey was conducted in 2022. A total of 2740 blood samples were collected from healthy individuals spanning the age range of 0–59 years, representing diverse demographic strata across 11 prefectures in Zhejiang Province in China. The sera were tested for measles and rubella IgG antibodies to determine positivity rates and geometric mean concentrations (GMCs). Results: The overall positivity rate for the measles IgG antibody was 85.3%, with a GMC of 588.30 mIU/mL. The positivity rate for the rubella IgG antibody was 70.9%, and the GMC was 35.30 IU/mL. Measles IgG antibody positivity rates across the 0–11 months, 12–23 months, 24–35 months, 3–5 years, 6–9 years, 10–14 years, 15–19 years, 20–29 years, and 30–59 years age groups were 63.1%, 92.5%, 97.0%, 94.0%, 85.8%, 77.3%, 86.9%, 84.9%, and 88.7%, respectively (trend χ2 = 118.34, p < 0.001). Correspondingly, rubella antibody positivity rates for these same age brackets were 55.9%, 87.9%, 94.7%, 88.2%, 69.9%, 54.2%, 72.6%, 67.5%, and 74.3% (trend χ2 = 199.18, p < 0.001). Both univariate and multivariate analyses consistently demonstrated that age, immunization history, and differing economic levels were significant factors contributing to variations in antibody levels. Conclusions: The seroprevalence of measles and rubella was lower than that required for herd immunity. Periodic vaccination campaigns should be launched to increase immunity.

immunology,medicine, research & experimental
Acceptance of Rubella-Containing Vaccine and Factors Associated with Acceptance among Women of Reproductive Age in China: A Cross-Sectional Study

Xia Xu,Siyu Liu,Xiaoqi Wang,Aodi Huang,Jun Li,Yang Zhou,Lei Wang,Yong Qin,Yu Ma,Shuyi An,Jun Liu,Lin Tang,Zundong Yin,Fuzhen Wang

DOI: https://doi.org/10.3390/vaccines12101153

2024-10-09

Vaccines

Abstract:Objectives: To investigate the acceptance and factors influencing acceptance of rubella-containing vaccine (RCV) among women of reproductive age in Guangdong, Henan, Hubei, Liaoning, Shanxi, Sichuan and Zhejiang provinces of China. Methods: Using a stratified sampling method, we selected one urban and one rural community health services center in each of two cities in seven provinces. From these centers, we recruited women 15–49 years of age to complete a questionnaire on their willingness to receive RCV and factors influencing willingness. The survey instrument was adapted from the behavioral and social drivers (BeSD) of vaccination survey tool developed by the World Health Organization. Results: Among 1286 participants, 981 (76.3%) were willing to receive RCV. Awareness of rubella ranged from 12.4% to 70.6%. Willingness to receive RCV differed significantly by region, occupation, vaccination history, and awareness. All latent variables of the structural equation model (SEM) were positively correlated with willingness, and all standardized paths were statistically significant (p < 0.001). Thinking and Feeling had direct positive effects on Social Processes (β = 0.789) and Practical Issues (β = 0.542), thereby indirectly affecting motivation. Conclusions: Women of reproductive age had high willingness to receive the rubella vaccination, but their general awareness of rubella was relatively low. It is necessary to strengthen the health education of women of reproductive age regarding rubella to improve RCV coverage.

immunology,medicine, research & experimental
Evaluating the effect of measles and rubella mass vaccination campaigns on seroprevalence in India: a before-and-after cross-sectional household serosurvey in four districts, 2018-2020

Manoj V Murhekar,Nivedita Gupta,Alvira Z Hasan,Muthusamy Santhosh Kumar,V Saravana Kumar,Christine Prosperi,Gajanan N Sapkal,Jeromie Wesley Vivian Thangaraj,Ojas Kaduskar,Vaishali Bhatt,Gururaj Rao Deshpande,Ullas Padinjaremattathil Thankappan,Avi Kumar Bansal,Sanjay L Chauhan,Gangandeep Singh Grover,Arun Kumar Jain,Ragini N Kulkarni,Santanu Kumar Sharma,Itta K Chaaithanya,Sanchit Kharwal,Sunil K Mishra,Neha R Salvi,Sandeep Sharma,Nilanju P Sarmah,R Sabarinathan,Augustine Duraiswamy,D Sudha Rani,K Kanagasabai,Abhishek Lachyan,Poonam Gawali,Mitali Kapoor,Arpit Kumar Shrivastava,Saurabh Kumar Chonker,Bipin Tilekar,Babasaheb V Tandale,Mohammad Ahmad,Lucky Sangal,Amy Winter,Sanjay M Mehendale,William J Moss,Kyla Hayford

DOI: https://doi.org/10.1016/S2214-109X(22)00379-5

Abstract:Background: India did phased measles-rubella supplementary immunisation activities (MR-SIAs; ie, mass-immunisation campaigns) targeting children aged 9 months to less than 15 years. We estimated measles-rubella seroprevalence before and after the MR-SIAs to quantify the effect on population immunity and identify remaining immunity gaps. Methods: Between March 9, 2018 and March 19, 2020 we did community-based, cross-sectional serosurveys in four districts in India before and after MR-SIAs. 30 villages or wards were selected within each district, and one census enumeration block from each was selected as the survey cluster. Households were enumerated and 13 children in the younger age group (9 months to <5 years) and 13 children in the older ager group (5 to <15 years) were randomly selected by use of computer-generated random numbers. Serum samples were tested for IgG antibodies to measles and rubella viruses by enzyme immunoassay. Findings: Specimens were collected from 2570 children before the MR-SIA and from 2619 children afterwards. The weighted MR-SIA coverage ranged from 73·7% to 90·5% in younger children and from 73·6% to 93·6% in older children. Before the MR-SIA, district-level measles seroprevalence was between 80·7% and 88·5% among younger children in all districts, and between 63·4% and 84·5% among older children. After the MR-SIA, measles seroprevalence among younger children increased to more than 90% (range 91·5 to 96·0) in all districts except Kanpur Nagar, in which it remained unchanged 80·4%. Among older children, measles seroprevalence increased to more than 90·0% (range 93·7% to 96·5%) in all districts except Hoshiarpur (88·7%). A significant increase in rubella seroprevalence was observed in all districts in both age groups, with the largest effect in Dibrugarh, where rubella seroprevalence increased from 10·6% to 96·5% among younger children. Interpretation: Measles-rubella seroprevalence increased substantially after the MR-SIAs but the serosurvey also identified remaining gaps in population immunity. Funding: The Bill & Melinda Gates Foundation and Indian Council of Medical Research.
Increased measles and rubella seroprevalence in children using residual blood samples from health facilities and household serosurveys after supplementary immunization activities in two districts in India

Christine Prosperi,Alvira Z. Hasan,Amy K. Winter,Itta Krishna Chaaithanya,Neha R. Salvi,Sandeep Sharma,Avi Kumar Bansal,Sanjay L. Chauhan,Ragini N. Kulkarni,Abhishek Lachyan,Poonam Gawali,Mitali Kapoor,Arpit Kumar Shrivastava,Saurabh K. Chonker,Vaishali Bhatt,Ojas Kaduskar,Gururaj Rao Deshpande,Ignacio Esteban,R. Sabarinathan,Velusamy Saravana Kumar,Shaun A. Truelove,Muthusamy Santhosh Kumar,Jeromie W. Vivian Thangaraj,Lucky Sangal,Sanjay M. Mehendale,Gajanan N. Sapkal,Nivedita Gupta,Kyla Hayford,William J. Moss,Manoj V. Murhekar

DOI: https://doi.org/10.1017/s0950268824001353

2024-11-24

Epidemiology and Infection

Abstract:Residual blood specimens provide a sample repository that could be analyzed to estimate and track changes in seroprevalence with fewer resources than household-based surveys. We conducted parallel facility and community-based cross-sectional serological surveys in two districts in India, Kanpur Nagar District, Uttar Pradesh, and Palghar District, Maharashtra, before and after a measles-rubella supplemental immunization activity (MR-SIA) from 2018 to 2019. Anonymized residual specimens from children 9 months to younger than 15 years of age were collected from public and private diagnostic laboratories and public hospitals and tested for IgG antibodies to measles and rubella viruses. Significant increases in seroprevalence were observed following the MR SIA using the facility-based specimens. Younger children whose specimens were tested at a public facility in Kanpur Nagar District had significantly lower rubella seroprevalence prior to the SIA compared to those attending a private hospital, but this difference was not observed following the SIA. Similar increases in rubella seroprevalence were observed in facility-based and community-based serosurveys following the MR SIA, but trends in measles seroprevalence were inconsistent between the two specimen sources. Despite challenges with representativeness and limited metadata, residual specimens can be useful in estimating seroprevalence and assessing trends through facility-based sentinel surveillance.

infectious diseases,public, environmental & occupational health
The pharmacology of a series of new sympatholytic agents.

M. Nickerson,L. Goodman

Abstract:
Measles and Rubella Serosusceptibity Among Population Vaccinated with Different Schedule of Vaccination: The Potential Impact on Measles Elimination in Iran.

Hana Saffar,Maryam Khalifeloo,Mohammed-Jafar Saffar,Ali-Reza Abdollahi,Mohammad-Reza Parsaei,Gholam-Reza Ghorbani,Samaneh Salarvand,Mohsen Aarabi

DOI: https://doi.org/10.21203/rs.3.rs-40094/v1

2020-07-09

Abstract:Abstract Background : In addition to schedule 2-doses monovalent measles vaccine (mMV) immunization of Iranian children since 1984, a nationwide campaign of measles-rubella (MR) immunization among 5- 25 years-old population in December 2003 was conducted. From 2004 mMV was replaced with measles- mumps-rubella (MMR) vaccine. Despite a high vaccination coverage, outbreaks of measles occurred in the country. Study was designed to investigate seroimmunity against measles and rubella among various age groups of population who were vaccinated with different schedule since 1984. Also, immunologic response to revaccination in seronegative subjects was evaluated. Methods: From 1 November 2017 to 30 June 2018 a cross- sectional study among 7- 33 year old healthy population with documented history of measles vaccination was conducted. Based on their age and history of vaccination categorized as GA: 20-23 years old; vaccinated with 1-2 dose of mMV, and also MR revaccinated. GB: 15-19 years, vaccinated only with 2- doses of mMV at the ages of 9 and 15 months. GC: 12-14 years and GD: 7-11 years; vaccinated with 2- dose of MMR vaccine at the ages 15 months - 6 years, and 12-18 month respectively. Collected sera were assessed to measure antimeasles and antirubella IgG antibodies concentration. Four to 6 weeks after revaccination of seronegative subjects, antimeasles-antirubella IgM and IgG antibodies were rechecked. Collected data were analyzed using descriptive statistical methods. Results : Totally 635 individuals, 312 female were included. Relative distribution of subjects in each group was as: GA: 98, GB: 295, GC: 139, and GD: 103 persons. Overall, 12.28% and 18.4% of population were soronegative, and varied greatly between groups: 2%-0/0%, 15.2%- 25.0%, 11.5%- 17.2%; and 14.6%-18.4% to measles and rubella, respectively. After revaccination, 92% and 94.9% showed 1gG response to measles and rubella vaccine respectively. Conclusion: Despite high coverage rate with measles containing vaccine, a significant numbers of vaccinated subjects lost their seroprotection, possibly because of secondary vaccine failure. This may affect measles-rubella elimination goal in the country. If these data were confirmed by further studies, more strengthen regional/ national supplementary immunization activity should be considered.
Age-specific prevalence of IgG against measles/rubella and the impact of routine and supplementary immunization activities – a multistage random cluster sampling study with mathematical modelling

Masahiko Hachiya,Emilia Vynnycky,Yoshio Mori,Hung Thai Do,Mai Kim Huynh,Long Hoang Trinh,Duy Duc Nguyen,Nhu Anh Thi Tran,Thanh Tien Hoang,Hai Hang Thi Hoang,Ngoc Dieu Thi Vo,Thieu Hoang Le,Yasunori Ichimura,Shinsuke Miyano,Sumiyo Okawa,Moe Moe Thandar,Yuta Yokobori,Yosuke Inoue,Tetsuya Mizoue,Makoto Takeda,Kenichi Komada

DOI: https://doi.org/10.1016/j.ijid.2024.107053

IF: 12.073

2024-04-19

International Journal of Infectious Diseases

Abstract:Background : Vietnam continues to have measles and rubella outbreaks following supplementary immunization activities (SIA) and routine immunization despite both having high reported coverage. To evaluate immunization activities, age-specific immunity against measles and rubella, and the number of averted Congenital Rubella Syndrome (CRS) cases, must be estimated. Methods : Dried blood spots were collected from 2,091 randomly selected individuals aged 1-39 years. Measles and rubella virus-specific immunoglobulin G (IgG) were measured by enzyme immunoassay. Results were considered positive at ≥120 mIU/mL for measles and ≥10 IU/mL for rubella. The number of CRS cases averted by immunization since 2014 were estimated using mathematical modelling. Results: Overall IgG seroprevalence was 99.7% (95%CI: 99.2-99.9) for measles and 83.6% (95%CI : 79.3-87.1) for rubella. Rubella IgG seroprevalence was higher among age groups targeted in the SIA than in non-targeted young adults (95.4% [95%CI: 92.9-97.0] vs. 72.4% [95%CI: 63.1-80.1]; P < 0.001). The estimated number of CRS cases averted in 2019 by immunization activities since 2014 ranged from 126 (95%CI: 0-460) to 883 (95%CI: 0-2271) depending on the assumed post-vaccination reduction in the force of infection. Conclusions : The results suggest the SIA was effective, while young adults born before 1998 who remain unprotected for rubella require further vaccination.

infectious diseases

Delta-9-tetrahydrocannabinol-induced catalepsy in mice is enhanced by pretreatment with flurazepam or chlordiazepoxide

Seroprevalence and risk factors for rubella infection in pregnant women attending a tertiary hospital in Kano-Nigeria

The impact of sub-national heterogeneities in demography and epidemiology on the introduction of rubella vaccination programs in Nigeria

Rubella immunity among pregnant women and the burden of congenital rubella syndrome (CRS) in India, 2022

Rubella epidemiology in Lesotho after vaccine introduction: a five-year review, 2018-2022

Medical x-ray exposure of the human embryo and fetus.

Sociodemographic and Economic Characteristics of Susceptibility to Rubella among Women Preparing for Pregnancy in Rural China

Rubella antibody levels in the healthy Chinese population: a meta-analysis

Symbol Spaced Adaptive MIMO Equalization for Ultrahigh Bit Rate Metro Coherent Optical Links

Do adolescents need a rubella vaccination campaign? Rubella serosurvey among healthy children in Hangzhou, China

Congenital rubella syndrome, a case series

Vulnerability Analysis of Web-based Applications

[100 years of child psychology research].

Rubella Immunity in Women of Childbearing Age, Eight Years After the Immunization Program in Iran

A Serological Survey of Measles and Rubella Antibodies among Different Age Groups in Eastern China

Acceptance of Rubella-Containing Vaccine and Factors Associated with Acceptance among Women of Reproductive Age in China: A Cross-Sectional Study

Evaluating the effect of measles and rubella mass vaccination campaigns on seroprevalence in India: a before-and-after cross-sectional household serosurvey in four districts, 2018-2020

Increased measles and rubella seroprevalence in children using residual blood samples from health facilities and household serosurveys after supplementary immunization activities in two districts in India

The pharmacology of a series of new sympatholytic agents.

Measles and Rubella Serosusceptibity Among Population Vaccinated with Different Schedule of Vaccination: The Potential Impact on Measles Elimination in Iran.

Age-specific prevalence of IgG against measles/rubella and the impact of routine and supplementary immunization activities – a multistage random cluster sampling study with mathematical modelling